as 11-08-2024 10:36am EST
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
Upcoming Earnings Alert:
Get ready for potential market movements as Nkarta Inc. NKTX prepares to release earnings report on 11 Nov 2024.
Founded: | 2015 | Country: | United States |
Employees: | N/A | City: | SOUTH SAN FRANCISCO |
Market Cap: | 225.1M | IPO Year: | 2020 |
Target Price: | $18.20 | AVG Volume (30 days): | 760.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.94 | EPS Growth: | N/A |
52 Week Low/High: | $1.90 - $16.24 | Next Earning Date: | 11-11-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
NKTX Breaking Stock News: Dive into NKTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
19 hours ago
Simply Wall St.
21 days ago
Benzinga
a month ago
GlobeNewswire
2 months ago
Motley Fool
3 months ago
MT Newswires
3 months ago
GlobeNewswire
3 months ago
GlobeNewswire
3 months ago
The information presented on this page, "NKTX Nkarta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.